🔎 Trials Near Me

Beranda › Glioma › Florida › Miami

Uji klinis Glioma di Miami, FL

15 studi untuk Glioma mencari peserta di lokasi sekitar Miami (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

Menerima pesertaFase 1/2
  • University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
12 Months – 21 Years · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT05099003

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Menerima pesertaFase 2
  • Miami Cancer Institute, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07326566

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

Menerima pesertaFase 2
  • Nicklaus Children's Hospital, Miami
12 Months – 39 Years · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT06838676

Targeted Pediatric High-Grade Glioma Therapy

Menerima pesertaStudi observasional
  • University of Miami, Miami
12 Months – 39 Years · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

Menerima pesertaFase 2
  • University of Miami Hospital and Clinics, Miami
Usia 12 hingga 39 · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT06161974

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Menerima pesertaFase 3
  • University of Miami Health, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT05303519

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

Menerima pesertaFase 2
  • Nicklaus Children's Hospital, Miami
Usia 3 hingga 39 · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT05096481

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Menerima pesertaFase 2
  • University of Miami Hospital and Clinics, Miami
Usia 8 ke atas · Semua jenis kelamin · Diperbarui 27 Jul 2026 · NCT05503797

Pembrolizumab, Olaparib, and Temozolomide for People With Glioma

Menerima pesertaFase 2
  • BAPTIST ALLIANCE - MCI (Data Collection Only), Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Jul 2026 · NCT05188508

STARLITE for Unresectable High-Grade Gliomas

Menerima pesertaFase 1
  • University of Miami, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Jun 2026 · NCT06428045

PrOton Pulsed reduCed dOse Rate Radiotherapy for Recurrent CNS maligNancies Trial

Menerima peserta
  • Miami Cancer Institute at Baptist Health, Inc., Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Jun 2026 · NCT06397560

DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma

Menerima pesertaFase 2
  • University of Miami Hospital, Miami
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 28 Mei 2026 · NCT06264388

Non-invasive Glioma Characterization Through Molecular Imaging

Menerima peserta
  • University of Miami, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Apr 2026 · NCT03684109

DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma

Menerima pesertaFase 1/2
  • University of Miami, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Mar 2026 · NCT06504381

Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid Tumors

Menerima pesertaFase 1/2
  • University of Miami Hospital, Miami
Hingga usia 18 · Semua jenis kelamin · Diperbarui 20 Nov 2025 · NCT04299191

Uji klinis Glioma di kota lain

Studi lain di Miami

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.